Search

everythinglearnresearchcommunity

for

Search:↓

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

MTS24 marks a new type of skin cell that helps hair growth and repair.

The treatment is effective for mild alopecia areata but often causes mild side effects.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.

Applying InlB321/15 to wounds sped up healing in mice.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

15-lipoxygenase helps keep skin healthy by reducing inflammation.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Women with androgenetic alopecia have fewer terminal hairs, phenol in nail surgery is safe, and a new hair transplant method is faster and less damaging.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.